BIO-key International (NASDAQ:BKYI – Get Free Report) and Red Cat (NASDAQ:RCAT – Get Free Report) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings.
Analyst Ratings
This is a breakdown of current ratings and target prices for BIO-key International and Red Cat, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BIO-key International | 0 | 0 | 0 | 0 | N/A |
Red Cat | 0 | 0 | 1 | 0 | 3.00 |
Red Cat has a consensus target price of $4.00, suggesting a potential upside of 16.96%. Given Red Cat’s higher probable upside, analysts plainly believe Red Cat is more favorable than BIO-key International.
Volatility & Risk
Earnings and Valuation
This table compares BIO-key International and Red Cat”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BIO-key International | $6.96 million | 0.35 | -$8.52 million | N/A | N/A |
Red Cat | $17.84 million | 14.46 | -$24.05 million | ($0.46) | -7.43 |
BIO-key International has higher earnings, but lower revenue than Red Cat.
Insider & Institutional Ownership
26.5% of BIO-key International shares are held by institutional investors. Comparatively, 38.0% of Red Cat shares are held by institutional investors. 5.8% of BIO-key International shares are held by company insiders. Comparatively, 21.5% of Red Cat shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares BIO-key International and Red Cat’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BIO-key International | -93.18% | -673.82% | -111.89% |
Red Cat | -162.50% | -66.19% | -58.99% |
Summary
Red Cat beats BIO-key International on 8 of the 11 factors compared between the two stocks.
About BIO-key International
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
About Red Cat
Red Cat Holdings, Inc. engages in the provision of various products, services, and solutions to the drone industry. The company operates through two segments: Enterprise and Consumer. It built infrastructure to manages drone fleets and fly, and provide services remotely, navigate confined industrial interior spaces and dangerous military environment. Red Cat Holdings, Inc. is based in San Juan, Puerto Rico.
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.